Advisory Alpha’s Inspire Corporate Bond ETF IBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-12,369
Closed -$300K 536
2025
Q3
$300K Sell
12,369
-4,937
-29% -$119K 0.01% 414
2025
Q2
$416K Buy
17,306
+307
+2% +$7.28K 0.01% 298
2025
Q1
$404K Hold
16,999
0.01% 281
2024
Q4
$398K Buy
16,999
+101
+0.6% +$2.4K 0.01% 264
2024
Q3
$407K Hold
16,898
0.01% 264
2024
Q2
$394K Sell
16,898
-595
-3% -$13.9K 0.02% 250
2024
Q1
$411K Buy
17,493
+2,245
+15% +$52.8K 0.02% 243
2023
Q4
$360K Buy
+15,248
New +$349K 0.02% 233

Other funds holding IBD

Advisory Alpha's IBD Position: Q4 2025 in Review

Advisory Alpha sold out of Inspire Corporate Bond ETF (IBD) in Q4 2025, closing a stake of 12,369 shares — an estimated $300K sold.

Advisory Alpha first reported a position in IBD in Q4 2023 and held it in 8 quarters. The position peaked at $416K in Q2 2025. 99 funds tracked by Wall St. Rank hold IBD as of Q4 2025.

  • Advisory Alpha reported no remaining Inspire Corporate Bond ETF position as of Q4 2025 after selling out during the quarter.
  • Advisory Alpha sold 12,369 Inspire Corporate Bond ETF shares in Q4 2025, an estimated $300K.
  • Advisory Alpha first reported a position in Inspire Corporate Bond ETF in Q4 2023 and held it in 8 quarters.
  • Advisory Alpha's Inspire Corporate Bond ETF position peaked at $416K in Q2 2025.
  • 99 funds tracked by Wall St. Rank held Inspire Corporate Bond ETF as of Q4 2025.

Based on Advisory Alpha's 13F filing for Q4 2025, filed 6 Feb 2026.